Studie: „Krankheitsverändernde Ernährung“ bei Multipler Sklerose

Hier ist eine aktuelle Studie, die darauf eingeht, dass die analgetischen (betäubenden) und anti-spastischen Effekte von Cannabis, seinen Inhaltsstoffen und weitere endocannabinoid-verbessernde Stoffe und Ernährung sich positiv auf die Krankheit auswirken. Darüber hinaus scheinen auch FAAH-Hemmer des Endocannabioidsystems beteiligt zu sein:

„Disease modifying nutricals“ for multiple sclerosis.

Pharmacol Ther. 2015 Apr;148C:85-113. doi: 10.1016/j.pharmthera.2014.11.015. Epub 2014 Nov 27.

Schmitz K1, Barthelmes J1, Stolz L1, Beyer S1, Diehl O1, Tegeder I2.


The association between vitamin D and multiple sclerosis has (re)-opened new interest in nutrition and natural compounds in the prevention and treatment of this neuroinflammatory disease. The dietary amount and type of fat, probiotics and biologicals, salmon proteoglycans, phytoestrogens and protease inhibitor of soy, sodium chloride and trace elements, and fat soluble vitamins including D, A and E were all considered as disease-modifying nutraceuticals. Studies in experimental autoimmune encephalomyelitis mice suggest that poly-unsaturated fatty acids and their ‚inflammation-resolving‘ metabolites and the gut microflora may reduce auto-aggressive immune cells and reduce progression or risk of relapse, and infection with whipworm eggs may positively change the gut-brain communication. Encouraged by the recent interest in multiple sclerosis-nutrition nature’s pharmacy has been searched for novel compounds with anti-inflammatory, immune-modifying and antioxidative properties, the most interesting being the scorpion toxins that inhibit specific potassium channels of T cells and antioxidative compounds including the green tea flavonoid epigallocatechin-3-gallate, curcumin and the mustard oil glycoside from e.g. broccoli and sulforaphane. They mostly also inhibit pro-inflammatory signaling through NF-κB or toll-like receptors and stabilize the blood brain barrier. Disease modifying functions may also complement analgesic and anti-spastic effects of cannabis, its constituents, and of ‚endocannabinoid enhancing‘ drugs or nutricals like inhibitors of fatty acid amide hydrolase. Nutricals will not solve multiple sclerosis therapeutic challenges but possibly support pharmacological interventions or unearth novel structures.

Direkt zur Studie: PubMed: „Disease modifying nutricals“ for multiple sclerosis.